Dan Fitzpatrick is currently the Executive Director at Amgen, where they are responsible for clinical biomarkers programs in the Inflammation, Neuroscience, and Metabolic therapeutic areas. They previously held roles as a director at Amgen and a Senior Scientist at Pharmacopeia, and completed a post-doctoral fellowship at Genentech. Dan holds a Ph.D. in Biochemistry from the University of Toronto and a Bachelor of Science with Honours in Biological Chemistry from the University of New Brunswick.
Location
Ventura County, United States